Free Trial

Taglich Brothers' Rating of Cosmos Health on 2/20/2024

On February 20, 2024, Taglich Brothers updated its outlook on Cosmos Health (NASDAQ:COSM) with the action "Reiterated Rating", keeping a "Speculative Buy" rating. MarketBeat All Access subscribers can view the full ratings details, 12-month ROI, historical price target changes, and related news coverage on this page.

unlock icon  Upgrade to MarketBeat All Access

This premium research tool is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Already have an account? Log in here.

More Ratings from Taglich Brothers

DateCompanyAction
7/28/2025
Banzai International, Inc. stock logo
BNZI
Banzai International
Upgrade
6/23/2025
BGSF, Inc. stock logo
BGSF
BGSF
Upgrade
9/5/2023
Super League Enterprise, Inc. stock logo
SLE
Super League Enterprise
Reiterated Rating
4/10/2023
Biosig Technologies, Inc. stock logo
BSGM
Biosig Technologies
Reiterated Rating
4/6/2023
Air Industries Group stock logo
AIRI
Air Industries Group
Reiterated Rating
4/6/2023
DecisionPoint Systems, Inc. stock logo
DPSI
DecisionPoint Systems
Reiterated Rating
More Ratings From Taglich Brothers